£213.78

Springer Cancer Neutron Capture Therapy

Price data last checked 8 day(s) ago - will refresh soon

View at Amazon

We'll watch every seller, every day. One email when your price arrives.

This is the most expensive it has ever been. Walk away.

£214 today · previous high £214 · all-time low £213

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey
↓ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 83 days • 83 data points (No recent data available)

Historical
Generating forecast...
£213.78 £213.29 £213.39 £213.50 £213.61 £213.72 £213.83 08 April 2026 28 April 2026 19 May 2026 08 June 2026 29 June 2026

Price Distribution

Price distribution over 83 days • 1 price levels

Days at Price
83 days 0 21 42 62 83 £213 Days at Price

Price Analysis

Most common price: £213 (83 days, 100.0%)

Price range: £213 - £213

Price levels: 1 different prices over 83 days

Description

There are many human cancers which actively synthesize specific characteristic proteins such as melanomas, thyroid cancer and squamous cell carcinoma. Many cancer researchers have of course tried to utilize this specific activity as a key for the selective treatment of cancers. In the past for example, the molecular hybrid compound of DOPA, a substrate of melanin, and nitrogen mustard N-oxide hydrochloride, a ctyotoxic anti-tumor drug, was synthesized as Melphalan and used to treat malignant melanoma. A major problem arose though in that it was soon found to be highly suppressive toward bone marrow and quite toxic while not being remarkably effective. Thus, malignant melanoma could not be cured by it. Such failure led us to develop a novel bimodal therapeutic system which includes the use of non-toxic potentially cytocidal chemicals which selectively accumulate within the cancer cells and which are converted by a controllable modality into an actively cytocidal element in situ. We can now non-surgically cure malignant melanoma and glioblastoma with our selective cancer treatment, neutron capture therapy (NCT); as can be found in this volume. Included are 124 papers on the latest breaking developments discussed at the Sixth International Symposium on NCT for Cancer held in Kobe during the late autumn of 1994.

Product Specifications

Format
paperback
Domain
Amazon UK
Release Date
17 May 2013
Listed Since
06 August 2014

Barcode

No barcode data available

Similar Products You Might Like

Advances in Boron Neutron Capture Therapy (Non-serial Publications)
96% match

Advances in Boron Neutron Capture Therapy (Non-serial Publications)

£46.17 04 Jul 2026
Springer - Advances in Neutron Capture Therapy Book
96% match

Springer - Advances in Neutron Capture Therapy Book

Springer

£142.76 04 Jul 2026
Springer - Neutron Capture Therapy: Principles and Applications
95% match

Springer - Neutron Capture Therapy: Principles and Applications

Springer

£99.14 02 Jul 2026
Progress in Neutron Capture Therapy for Cancer: International Symposium Proceedings
95% match

Progress in Neutron Capture Therapy for Cancer: International Symposium Proceedings

Springer

£80.56 08 Mar 2026
Resistance to Ibritumomab in Lymphoma: 18 (Resistance to Targeted Anti-Cancer Therapeutics, 18)
94% match

Resistance to Ibritumomab in Lymphoma: 18 (Resistance to Targeted Anti-Cancer Therapeutics, 18)

Springer

£75.01 10 Mar 2026
Neuro-Oncology: Advances in Diagnosis, Treatment, and Research
94% match

Neuro-Oncology: Advances in Diagnosis, Treatment, and Research

£44.99 07 Mar 2026
Targeted Radionuclide Tumor Therapy: Biological Aspects
94% match

Targeted Radionuclide Tumor Therapy: Biological Aspects

Springer

£152.03 01 Jul 2026
Robotergeführte Radiochirurgie: Extracranielle Indikationen
94% match

Robotergeführte Radiochirurgie: Extracranielle Indikationen

De Gruyter

£81.16 18 Apr 2026
Weichteilsarkome: Diagnostik und aktuelle Therapiestrategien
94% match

Weichteilsarkome: Diagnostik und aktuelle Therapiestrategien

Springer

£46.99 01 Apr 2026
Hodgkin’s Disease in Children: Controversies and Current Practice: 41 (Cancer Treatment and Research)
94% match

Hodgkin’s Disease in Children: Controversies and Current Practice: 41 (Cancer Treatment and Research)

Springer

£165.83 12 Apr 2026
Neuroblastoma: Molecular Mechanisms and Therapeutic Interventions
94% match

Neuroblastoma: Molecular Mechanisms and Therapeutic Interventions

Academic Press

£98.89 11 Mar 2026
New Approaches in the Treatment of Cancer (Cancer Etiology, Diagnosis and Treatments)
94% match

New Approaches in the Treatment of Cancer (Cancer Etiology, Diagnosis and Treatments)

£75.99 06 Mar 2026
Tumors of the Pediatric Central Nervous System
94% match

Tumors of the Pediatric Central Nervous System

Thieme

£182.40 11 Apr 2026
Evidence based practice in Neuro-oncology
94% match

Evidence based practice in Neuro-oncology

Springer

£81.84 04 Jul 2026
Nanooncology: Engineering nanomaterials for cancer therapy and diagnosis (Nanomedicine and Nanotoxicology)
94% match

Nanooncology: Engineering nanomaterials for cancer therapy and diagnosis (Nanomedicine and Nanotoxicology)

Springer

£118.99 13 Apr 2026
UICC Manual of Clinical Oncology
94% match

UICC Manual of Clinical Oncology

Wiley

£124.37 25 Jun 2026
14 MeV Neutrons: Physics and Applications
94% match

14 MeV Neutrons: Physics and Applications

CRC Press

£49.91 04 Jul 2026
Cancer Management in Man: Detection, Diagnosis, Surgery, Radiology, Chronobiology, Endocrine Therapy: 9 (Cancer Growth and Progression, 9)
94% match

Cancer Management in Man: Detection, Diagnosis, Surgery, Radiology, Chronobiology, Endocrine Therapy: 9 (Cancer Growth and Progression, 9)

Springer

£174.97 28 Mar 2026
Diagnosis and Management of Malignant Solid Tumors in Infants and Children: 37 (Developments in Oncology, 37)
94% match

Diagnosis and Management of Malignant Solid Tumors in Infants and Children: 37 (Developments in Oncology, 37)

Springer

£103.65 10 Apr 2026
BORON AND GADOLINIUM NEUTRON CAPTURE THERAPY FOR CANCER TREATMENT
94% match

BORON AND GADOLINIUM NEUTRON CAPTURE THERAPY FOR CANCER TREATMENT

World Scientific Publishing Company

£66.05 01 Jul 2026
Cancer and its Management
94% match

Cancer and its Management

Wiley

£69.28 23 Jun 2026
Cancer Management in Man: Detection, Diagnosis, Surgery, Radiology, Chronobiology, Endocrine Therapy: 9 (Cancer Growth and Progression)
94% match

Cancer Management in Man: Detection, Diagnosis, Surgery, Radiology, Chronobiology, Endocrine Therapy: 9 (Cancer Growth and Progression)

Springer

£175.38 08 Apr 2026
Pediatric Cancer, Volume 2: Teratoid/Rhabdoid, Brain Tumors, and Glioma
94% match

Pediatric Cancer, Volume 2: Teratoid/Rhabdoid, Brain Tumors, and Glioma

Springer

£98.34 09 Mar 2026
Controversies in the Management of Lymphomas: Including Hodgkin’s disease: 16 (Cancer Treatment and Research, 16)
94% match

Controversies in the Management of Lymphomas: Including Hodgkin’s disease: 16 (Cancer Treatment and Research, 16)

Springer

£85.30 08 Mar 2026